Breast papillary lesions: comparative analysis of core needle biopsy and surgical excision findings in a single-center retrospective cohort with literature review.
Lesiones papilares mamarias: análisis comparativo de los hallazgos de la biopsia con aguja gruesa y de la escisión quirúrgica en una cohorte retrospectiva de un solo centro, con revisión de la literatura.
Abstract
This retrospective study aimed to identify histopathological and immunohistochemical predictors of malignancy requiring surgical excision among papillary breast lesions diagnosed by core-needle biopsy (CNB). Fifty- three women with CNB-diagnosed papillary breast lesions who subsequently underwent surgical excision at the İzmir Bakırçay University Çiğli Hospital be- tween January 2015 and January 2025 were included. Clinical, radiological, and pathological data were analyzed. Twenty-eight patients (52.8%) were ≤50 years of age, and 21 lesions (39.6%) were larger than 3 cm. Surgical excision revealed benign lesions in 24 cases, malignant lesions in 16 cases, and intracystic solid carcinoma or atypical ductal hyperplasia in 13 cases. The malignancy/ atypia group (45.2%) showed a significantly higher frequency of myoepithelial cell loss (p<0.001) and microcalcifications (p=0.028), and uniform, strong estrogen receptor positivity (100%) on CNB. Benign lesions were more commonly peripherally located (p=0.049). No significant associations were observed with age, Breast Imaging Reporting and Data System (BI-RADS) category, or lesion size. These findings indicate that loss of myoepithelial cells and estrogen receptor positivity are strong predictors of malignancy and support the routine incorporation of immunohistochemical evaluation into CNB-based risk stratification.
Downloads
References
Puccini R, Sanvido V, Waitzberg A, Facina G, Nazario A. Underestimation in core-needle biopsies of papillary breast lesions: a retrospective cohort from a university center. In: Proceedings of the San Antonio Breast Cancer Symposium. Clin Cancer Res. 2025; 31(12): 1-10-09.
Tay TKY, Tan PH. Papillary neoplasms of the breast-reviewing the spectrum. Mod Pathol. 2021; 34:1044-1061. doi:10.1038/41379-020-00732-3
WHO Classification of Tumours Editorial Board. Breast tumours. IARC, Lyon, France, in: WHO classification of tumours. 2019;
Naowaset P. Prognosis and clinical outcome of papilloma neoplasm of the breast: An observational study. Cancer Treat Res Commun. 2025; 43:100900. doi:10.1016/j.etare.2025.100900
Wang Y, Song EC. Papillary neoplasm of the breast A review and update. Hum Pathol Rep. 2021; 26: 300581. doi:10.1016/j.hpr.2021.300581.
Dnyanmote A, Himashree MP. Unusual Case of Papillary Carcinoma of the Breast. Cureus. 2024;16(7):e63568. doi:10.7759/cureus.63568
Sukpanich R, Lertsithichai P, Chirappapha P. Prognosis and clinical outcome of papillary carcinoma of the breast at A Tertiary Care Hospital. Thai J. Surgery. 2019; 40:101-106.
Tian H, Li G, Zheng J, Ding Z, Luo Y, Mai S, et al. Comparing core needle biopsy and surgical excision in breast cancer diagnosis: implications for clinical practice from a retrospective cohort study. Quant Imaging Med Surg. 2024;14(12):8281-8293. doi:10.21037/qims-24-198.
Thai JN, Vickery J, Boyraz B, Crowley C, Saksena MA, Vladislav V. Papillary Neoplasms of the Breast: WHO Classification, Multimodality Imaging, and Radiologic-Pathologic Correlation. RadioGraphics. 2025; 45(8) doi:10.1148/rg.240091
Sydnor MK, Wilson JD, Hijaz TA, Massey HD. Shaw de Paredes ES. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Radiology. 2007; 242(1):58-62. doi:10.1148/radiol.2421031988.
Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008; 52(1):20-29. doi:10.1111/j.1365-2559.2007.02898.
Rakha EA, Ellis IO. Diagnostic challenges in papillary lesions of the breast. Pathology. 2018; 50(1):100-110. doi:10.1016/j.pathol.2017.10.005.
Piscuoglio S, Ng CK, Martelotto LG, Eberle CA, Cowell CF, Natrajanet R, et al. Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast. Mol Oncol. 2014; 8(8):1588-1602. doi:10.1016/j.molonc.2014.06.011
Andre F, Ismaila N, Henry NL, Somerfield MR, Bast RC, Barlow W, et al. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx. J Clin Oncol. 2019; 37:1956-64. doi:10.1200/JCO.19.00945
Nuñez, DL, González FC, Ibargüengoitia MC, Fuentes Corona RE, Hernández Villegas AC, Zubiate, ML, et al. Papillary Lesions of the Breast: A Review. Breast Cancer Management. 2020; 9(4). doi:10.2217/bmt-2020-0028
Pathmanathan N, Albertini AF, Provan P, Milliken JS, Salisbury EL, Bilouset AM, et al. Diagnostic evaluation of papillary lesions of the breast on core biopsy. Mod Pathol. 2010; 23:1021-1028. doi:10.1038/modpathol.2010.81
Bruening W, Fontanarosa J, Tipton K, Treadwell JL, Schoelles K. Systematic review: Comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions. Ann Intern Med. 2009; 152: 238-46. doi:10.1059/0003-4819-152-1-201001050-00190.















